Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2026-04-11 @ 5:00 AM
Study NCT ID:
NCT01923168
Status:
COMPLETED
Last Update Posted:
2018-09-14
First Post:
2013-08-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CBYL719A2201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None